Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Clinical trial NCT06089369 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06089369
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.